IPthinktank
IP ThinkTank blogIP Scorecards

back to scorecards index

Browse Scorecards

Click here to receive Global IP Scorecards™ by email

CONTACTSUBSCRIBE

Nexium (Esomeprazole)

Contribute to this scorecard

Esomeprazole is a proton pump inhibitor (brand names Nexium®; Lucen®; Esopral® and Axagon® in Italy) developed and marketed by AstraZeneca which is used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD) and Zollinger-Ellison syndrome.

Copyright Thursday, January 17, 2008 Duncan Bucknell

Updates by Country

   (Click on a country name to view)